Infect Disord Drug Targets
. 2020 Nov 26.
doi: 10.2174/1871526520999201126203510. Online ahead of print.
COVID-19 Treatment Success After Repeat Courses of Azithromycin: a report of three cases
Fereshteh Ghiasvand 1 , Maryam Ghadimi 2 , Sara Sadr 3 , Fatemeh Jafari 4 , Navid Manafi 4 , Zahra Ah-Madinejad 1 , Samaneh Tirgar 5 , Seyed Ahmad Seyed Alinaghi 6
Affiliations
- PMID: 33243134
- DOI: 10.2174/1871526520999201126203510
Abstract
Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is lim-ited data on its efficacy. We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful outcome.
Keywords: Atazanavir; Azithromycin; Coronavirus disease 2019 (COVID-19); Hydroxychloroquine; Ritonavir; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).